 |
|
 |
 |
 |
|
|
|
3SBio
Fully integrated, profitable biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China
IPO in May 2015 (HKSE: 1530)
|
AADI Bioscience
Clinical stage biopharmaceutical company developing a nanoparticle albumin-bound mTOR inhibitor based on sirolimus or rapamycin, also known as nab-rapamycin |
AccuraGen
Molecular diagnostics based in Shanghai and Silicon Valley providing cell-free DNA based liquid biopsy tests for personalized cancer treatment and monitoring |
Adaptive Biotechnologies
Diagnostics company developing immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems
IPO in June 2019 (NASDAQ: ADPT) |
 |
|
 |
 |
|
|
|
|
AK Medical
Largest domestic manufacturer of hip and knee artificial joints in China
IPO in December 2017 (HKSE: 1789) |
Albireo Pharma
Clinical stage biopharma company focused on the development of novel bile acid modulators to treat orphan pediatric liver diseases, and other adult liver diseases and disorders
(NASDAQ:ALBO) |
Alpine Immune Sciences
Biotech company developing innovative treatments for patients suffering from cancer and autoimmune/inflammatory diseases
(NASDAQ:ALPN) |
AnHeart Therapeutics
Clinical stage biopharmaceutical company based in China focused on the acquisition, development and commercialization of oncology products |
 |
|
 |
|
|
|
|
|
Apexigen
Clinical-stage biopharmaceutical company focusing on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology |
Arcus Biosciences
Clinical-stage biotechnology company focused on the discovery and development of innovative cancer immunotherapies
IPO in March 2018 (NASDAQ:RCUS) |
Ariagen
Biotech company founded by Decheng Capital to develop a novel class of small molecules as cancer immunotherapies |
Ark Biosciences
Ark Biosciences is a biotech startup company focusing on innovative drug discovery and development, especially in the respiratory virus field, for world-wide markets |
 |
 |
 |
|
|
|
|
|
ARMO Biosciences
Late-stage immuno-oncology company that is developing a pipeline of novel, proprietary products that activate the immune system of cancer patients to recognize and eradicate tumors
Acquired by Eli Lilly in May 2018 |
BCFoods
Global leading food/vegetable ingredient supplier with a full supply chain control and strategically aligned global distribution platform |
BeyondSpring
Clinical-stage biopharmaceutical company developing plinabulin, an anti-cancer agent
(NASDAQ:BYSI) |
Bioheng
Biotech company based in China developing universal CAR-T products |
|
 |
|
 |
|
|
|
|
CardiMED
Medical device company addressing the large and growing market for advanced cardiovascular devices in China |
Cellular Research
Life science tools company developing a next-generation single cell preparation technology
Acquired by Becton Dickinson in August 2015 |
Centricity Vision
Medical device company focused on development and commercialization of its Zepto? device for cataract surgery |
Checkmate Pharmaceuticals
Clinical stage biopharma company that is leveraging its expertise in the field of CpG oligonucleotides to discover and develop immunotherapies designed to increase the efficacy of existing immunotherapies
IPO in August 2020 (NASDAQ: CMPI) |
 |
|
|
 |
|
|
|
|
Cirina
Diagnostics compaby based in Hong Kong and Silicon Valley developing proprietary plasma-based early cancer screening/detection utilizing next-generation sequencing
Acquired by GRAIL in May 2017 |
Cue Health
Molecular diagnostics company developing products that can be used in clinical or at-home settings |
Encodia
Life science tools company that plans to develop and commercialize next-generation proteomic assays which can be decentralized |
EpimAb Biotherapeutics
Biopharmaceutical company dedicated to generating novel bi-specific antibody therapeutics based on its proprietary FIT-Ig (Fabs-In-Tandem) platform |
 |
 |
 |
|
|
|
|
|
Everest Medicines
Biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Greater China and other parts of Asia
IPO in October 2020 (HKSE: 1952) |
GenapSys
Life science tools company developing a disruptive DNA-sequencing technology that enables fast, accurate, and ultra-low cost genetic testing and research |
GeneMDx
Diagnostic company with commercialization in China and innovative technologies developed in Silicon Valley |
GeneWEAVE
Diagnostics company developing and commercializing products for bacterial susceptibility testing for surveillance of hospital acquired infections
Acquired by Roche in August 2015 |
 |
 |
 |
 |
|
|
|
|
GRAIL
Healthcare company whose mission is to detect cancer early, when it can be cured
Acquired by Illumina in September 2020 |
Guanlong Medical
The market leader in minimally invasive spine surgery devices in China |
GRIT Biotechnology
Biotech company developing tumor infiltration lymphocytes immunotherapy for solid tumors
|
GYT Healthcare Services
Leading domestic hemodialysis service provider in China
|
|
 |
 |
 |
|
|
|
|
Hummingbird Bioscience
Biotech company, with facilities in Singapore and Silicon Valley, focused on applying advances in systems biology to rapidly develop antibodies into successful cancer therapeutics
|
IMPACT Therapeutics
Clinical stage biopharmaceutical company based in China focusing on discovery and development of best-in-class anti-cancer drugs targeting a poly (ADP-ribose) polymerase (PARP) |
Insight Lifetech
Medical device company dedicated to developing world class interventional diagnostic cardiology devices
|
Invitae
Genetic information company with a mission to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people
IPO in February 2016 (NASDAQ: NVTA) |
|
|
|
 |
|
|
|
|
KeChow Pharma
Clinical-stage biotech based in China focused on developing small molecules for clinically validated oncology targets |
Ketai Medical
Medical device company focusing on registration and commercialization of innovative and FDA-approved prosthetic hip and knee joint implants for the China market |
Kind Pharmaceutical
Clinical stage biopharmaceutical company based in China focusing on discovery and development of best-in-class anemia drugs |
LevitasBio
Early stage life science tools company developing a single-cell imaging and profiling platform based on magnetic levitation technology invented at Stanford and Harvard universities |
 |
|
 |
 |
|
|
|
|
LYNK Pharmaceuticals
Preclinical stage biotech comapny focused on researching and developing JAK family small molecules |
Mammoth Biosciences
Healthcare company who is harnessing the diversity of nature to power the next-generation of CRISPR products |
MDCO
The market leader in ophthalmology medical device in China |
Mindstrong Health
Digital health startup developing and offering an artificial intelligence powered platform designed through an app to monitor patterns of interaction on smartphone devices to objective measures of brain function |
|
|
|
 |
|
|
|
|
Nalu Medical
Medical device company focused on development and commercialization of novel neurostimulation system |
Omniome
Life science tools company focused on development and commercialization of next generation DNA sequencing platform |
PackGene Biotech
PackGene is a CRO/CDMO service provider for global gene therapy and cell therapy researchers and developers |
Polares Medical
Medical device company developing a novel implant and delivery system for the treatment of mitral valve regurgitation |
 |
 |
 |
 |
|
|
|
|
ReadCoor
Life science tools company developing RNA sequencing technology by delivering the first panomic spatial sequencing platform
Acquired by 10X Genomics in October 2020 |
Scynexis
Biotech company developing innovative therapies for difficult-to-treat and often life-threatening infections
(NASDAQ:SCYX) |
Sema4
Patient-centered health intelligence company founded on the idea that more information, deeper analysis, and increased engagement will improve the diagnosis, treatment, and prevention of disease |
SentreHEART
Medical device company with a novel suture delivery and tissue closure device for for patients with atrial fibrillation
Acquired by Atricure in August 2018 |
|
 |
|
 |
|
|
|
|
SINO Medical Sciences Technology
Medical device company dedicated to developing, manufacturing and commercializing products for percutaneous coronary intervention for the Chinese market
IPO in October 2019 (SHA: 688108) |
Take2
Healthcare technology company aiming to disrupt healthcare inventions widely accessible to the public in China and Asia |
Terns Pharmaceuticals
Clinical stage biopharma company based in Shanghai and Silicon Valley developing oral, small molecule drugs for nonalcoholic steatohepatitis (NASH), a liver disease |
VelosBio
Biopharma company focused on developing an antibody-drug conjugate of cirmtuzumab, a ROR1 antibody
Acquired by Merck in November 2020 |
